drugset / Trial / NCT03219320
Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
RandomizedParallel-groupTriple-blindSupportive care
Summary
To evaluate the efficacy of multiple dose levels of NYX-2925 versus placebo in treating the neuropathic pain associated with Diabetic Peripheral Neuropathy.
Timeline
- Start
- 2017-06-27
- Primary completion
- 2018-11-02
- Completion
- 2018-11-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NYX-2925 | Small molecule | — | — |